Cardiovascular risk and statin prescription in primary care: an observational study, São Leopoldo, 2018-2021.
To present the cardiovascular risk strata based on the Global HEARTS Initiative calculator and analyze statin prescription among users of Primary Health Care in São Leopoldo, Rio Grande do Sul.
This was a cross-sectional observational study including users aged 18 years or older listed in the Cardiovascular Risk Operational Report. Categorical data were presented as absolute and relative frequencies and 95% confidence intervals (95%CI). Associations between categorical variables were analyzed using the chi-square test or Fisher's exact test, with statistical significance defined as p-value≤0.050.
It was possible to calculate the cardiovascular risk of 2,199 users. Most users presented low (41.4%; 95%CI 39.3; 43.5) or moderate risk (38.0%; 95%CI 36.0; 40.1), while 19.6% (95%CI 18.0; 21.3) had high risk and 1.0% (95%CI 0.6; 1.4) had very high risk. Statin prescription was recorded in 29.5% (95%CI 27.6; 31.4) of the medical records. There was a statistically significant association (p-value<0.001) between cardiovascular risk and statin prescription, with higher prescription frequency among high-risk users (41.2%).
Most Primary Health Care users in São Leopoldo had low to moderate cardiovascular risk. The prescription of statins was consistent with clinical guidelines, considering cardiovascular risk in decision-making; however, it was reached by less than one-third of the overall sample.
This was a cross-sectional observational study including users aged 18 years or older listed in the Cardiovascular Risk Operational Report. Categorical data were presented as absolute and relative frequencies and 95% confidence intervals (95%CI). Associations between categorical variables were analyzed using the chi-square test or Fisher's exact test, with statistical significance defined as p-value≤0.050.
It was possible to calculate the cardiovascular risk of 2,199 users. Most users presented low (41.4%; 95%CI 39.3; 43.5) or moderate risk (38.0%; 95%CI 36.0; 40.1), while 19.6% (95%CI 18.0; 21.3) had high risk and 1.0% (95%CI 0.6; 1.4) had very high risk. Statin prescription was recorded in 29.5% (95%CI 27.6; 31.4) of the medical records. There was a statistically significant association (p-value<0.001) between cardiovascular risk and statin prescription, with higher prescription frequency among high-risk users (41.2%).
Most Primary Health Care users in São Leopoldo had low to moderate cardiovascular risk. The prescription of statins was consistent with clinical guidelines, considering cardiovascular risk in decision-making; however, it was reached by less than one-third of the overall sample.
Authors
Micheletti Micheletti, Rosa Rosa, Dipp Dipp, Silva Silva, Campagnolo Campagnolo, Mercaus Mercaus, Brito Brito, Bonin Bonin
View on Pubmed